metaphit has been researched along with haloperidol in 2 studies
Studies (metaphit) | Trials (metaphit) | Recent Studies (post-2010) (metaphit) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
---|---|---|---|---|---|
68 | 0 | 4 | 20,330 | 1,753 | 3,294 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brasili, L; Di Toro, R; Giannella, M; Melchiorre, C; Piergentili, A; Pigini, M; Quaglia, W; Rossetti, L; Spampinato, S | 1 |
Brum, JM; Estafanous, FG; Murray, PA; Schubert, A; Tsuchida, H | 1 |
2 other study(ies) available for metaphit and haloperidol
Article | Year |
---|---|
1'-Benzyl-3,4-dihydrospiro[2H-1- benzothiopyran-2,4'-piperidine] (spipethiane), a potent and highly selective sigma1 ligand.
Topics: Animals; Guinea Pigs; Ligands; Piperidines; Rats; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Opioid; Receptors, Serotonin; Receptors, sigma; Sigma-1 Receptor; Spiro Compounds; Structure-Activity Relationship | 1998 |
Sigma receptor activation does not mediate fentanyl-induced attenuation of muscarinic coronary contraction.
Topics: Acetylcholine; Anesthetics, Intravenous; Animals; Coronary Vessels; Cyclazocine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fentanyl; Guanidines; Haloperidol; Muscarine; Muscarinic Agonists; Narcotic Antagonists; Narcotics; Pentazocine; Phencyclidine; Piperidines; Potassium Channel Blockers; Receptors, Dopamine; Receptors, sigma; Signal Transduction; Swine; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |